日本語 ／ English
NEWS
【New】Applications Open: HDO Free Trial & Collaborative Research Call 2026
BioJapan 2026（10/7～10/9, PACIFICO Yokohama）
Participation in the Research and Development Project Selected for AMED "Project Focused on Developing Key Technology for Discovering and Manufacturing Drugs for Next-Generation Treatment and Diagnosis (Drug Development Using Next-generation Drug-Delivery System)" (2nd Open Call)
BioJapan 2025（10/8～10/10, PACIFICO Yokohama）
Notice of article in Nikkei Biotech regarding the development of our ligands
Poster presentation at the 10th Annual Meeting of Nucleic Acids Therapeutics Society of Japan
HDO(Hetero-Duplex Oligonucleotide) Trial Campaign Announcement
Japan Healthcare Venture Summit 2024
Announcement on Completion of signing additional license agreement with Takeda Pharmaceutical Company Limited
BIO International Convention 2024
Japan Healthcare Venture Summit 2023
Announcement on Completion of signing additional license agreement with Takeda Pharmaceutical Co., Ltd.
